Barron’s 2024 Healthcare Roundtable panelists make the case for 21 healthcare companies of all stripes, including Humana, Novo Nordisk, BioLife Solutions, and more.

Eli Lilly and Company (NYSE: LLY) announced these new long-term results from the ADjoin long-term extension study, which will be presented at the European Academy of Dermatology and Venereology ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Earnings Report 4.488 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.399 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.600 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

VTYX Stock Rises on Strategic Equity Investment Deal With SNY Shares of Ventyx Biosciences (NASDAQ: VTYX) gained 7% on Monday after the company announced that it has entered into a $27 million ...

View Eli Lilly and Company (LLY) current and estimated P/E ratio data provided by Seeking Alpha.

Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our P/B Growth Investor model based on the published strategy of ...

Short interest in Eli Lilly and Co (NYSE:LLY) increased during the last reporting period, rising from 6.27M to 6.58M. This put 0.82% of the company's publicly available shares short. Short ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed yesterday at $935.02. According to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...